Return to study ST000241 main page   Show: (1)HMDB and KEGG pathways   (2)REACTOME pathways containing these metabolites

Select	Metabolite Name	Metabolite Id	Refmet Name	Ret. Index	Quant. m/z	Analysis Display
	Trihexosylceramide (d18:1/18:0)	ME699911	Hex3Cer 18:1;O2/18:0	26.25	1050.6955	FT-ICR-MS Negative ion mode
	3-O-Sulfogalactosylceramide (d18:1/24:1(15Z))	ME699854	SHexCer 18:1;O2/24:1	22.94	890.6409	FT-ICR-MS Positive ion mode
	Galactosylceramide (d18:1/14:0)	ME699751	GalCer 18:1;O2/14:0	26.28	672.5465	FT-ICR-MS Positive ion mode
	Ganglioside GT3 (d18:1/16:0)	ME699897	GT3 18:1;O2/16:0	28.53	1735.9082	FT-ICR-MS Positive ion mode
	Glucosylceramide (d18:1/12:0)	ME699739	GlcCer 18:1;O2/12:0	25.75	644.5133	FT-ICR-MS Positive ion mode
	Glucosylceramide (d18:1/26:0)	ME699828	GlcCer 18:1;O2/26:0	9.85	840.7336	FT-ICR-MS Positive ion mode
	Trihexosylceramide (d18:1/24:0)	ME699885	Hex3Cer 18:1;O2/24:0	25.44	1136.8074	FT-ICR-MS Positive ion mode